According to AIM ImmunoTech 's latest financial reports the company's total liabilities are $11.36 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $2.02 M | 146.34% |
2021-12-31 | $0.82 M | -75.08% |
2020-12-31 | $3.29 M | -55.01% |
2019-12-31 | $7.31 M | -15.67% |
2018-12-31 | $8.67 M | 57.54% |
2017-12-31 | $5.5 M | 63.08% |
2016-12-31 | $3.37 M | 38.72% |
2015-12-31 | $2.43 M | -45.15% |
2014-12-31 | $4.43 M | 72.67% |
2013-12-31 | $2.56 M | -80.24% |
2012-12-31 | $12.99 M | 134.3% |
2011-12-31 | $5.54 M | -3.23% |
2010-12-31 | $5.73 M | -8.99% |
2009-12-31 | $6.29 M | 277.86% |
2008-12-31 | $1.66 M | -23.78% |
2007-12-31 | $2.18 M | -67.26% |
2006-12-31 | $6.68 M | 10.83% |
2005-12-31 | $6.02 M | 61.45% |
2004-12-31 | $3.73 M | -10.18% |
2003-12-31 | $4.15 M | 183.88% |
2002-12-31 | $1.46 M | 15.09% |
2001-12-31 | $1.27 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() OPKO Health
OPK | $0.72 B | 6,246.99% | ๐บ๐ธ USA |
![]() Onconova Therapeutics ONTX | $12.15 M | 6.99% | ๐บ๐ธ USA |